Division of Teva Pharmaceutical Industries Ltd.
Latest From Pliva Inc.
California Supreme Court finds Novartis liable for alleged injuries from use of a generic version of Brethine even though they occurred six years after Novartis transferred the NDA; dissenting opinion says this will expose companies to "liability in perpetuity."
Chicago jury finds GSK failed to adequately warn about risk of suicidal behavior in patients over age 24 taking paroxetine; GSK argued that FDA had found no increased risk in this population.
Supreme Court asks the Solicitor General to weigh in on whether a state tort claim that Teva did not immediately update its generic Fosamax labeling is preempted by federal law; thousands of such suits have arisen in wake of high court’s Mensing decision.
House hearing illustrates the strange alliances the proposed rule has produced – Republicans standing with the generic industry in opposition to the reg – and allows FDA to offer a spirited defense of the origins of the policy.
- Therapeutic Areas
- Sidmak Laboratories Inc.
- North America
- Parent & Subsidiaries
- Teva Pharmaceutical Industries Ltd.
- Senior Management
- Kurt J Orlofski, Pres. & CEO
- Contact Info
Phone: (800) 922-0547
72 Eagle Rock Ave.
East Hanover, NJ 07936
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.